(Q44001260)

28 November 2017

Long-term survivors after gamma knife radiosurgery for brain metastases (English)

1 reference

28 November 2017

3

1 reference

28 November 2017

1

Douglas Kondziolka

1 reference

28 November 2017

Juan J Martin

2

1 reference

28 November 2017

David M Friedland

4

1 reference

28 November 2017

Adam M Brufsky

5

1 reference

28 November 2017

Joseph Baar

6

1 reference

28 November 2017

Sanjiv Agarwala

7

1 reference

28 November 2017

John M Kirkwood

8

1 reference

28 November 2017

L Dade Lunsford

9

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

28 November 2017

1 reference

28 November 2017

104

1 reference

28 November 2017

12

1 reference

28 November 2017

2784-2791

1 reference

A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.

28 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Linear accelerator-based stereotaxic radiosurgery for brain metastases:the influence of number of lesions on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Stereotactic radiosurgery for patients with nonsmall cell lung carcinoma metastatic to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

A single institutional outcome analysis of Gamma Knife radiosurgery for single or multiple brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Radiosurgery Followed by Planned Observation in Patients with One to Three Brain Metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Linear accelerator radiosurgery in the treatment of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Radiosurgery with or without whole-brain radiotherapy for brain metastases: the patients' perspective regarding complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

Radiation therapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Distribution of brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

The palliation of brain metastases: Final results of the first two studies by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Equivalence of radiation schedules for the palliative treatment of brain metastases in patients with favorable prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

METASTATIC BRAIN TUMORS. RESULTS OF SURGICAL AND NONSURGICAL TREATMENT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Stereotactic radiosurgery for brain metastases from breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Analysis of the proliferative potential of residual tumor after radiosurgery for intraparenchymal brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Brain metastases in patients with no known primary tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Stereotactic radiosurgery for brain metastasis from renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Stereotactic irradiation without whole-brain irradiation for single brain metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Subacute brain atrophy after radiation therapy for malignant brain tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Radiation-induced dementia in patients cured of brain metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21545

7 January 2021

Identifiers

DOI

10.1002/CNCR.21545

1 reference

28 November 2017

1 reference